With Brazil's Vote Behind It, the Safety Review Grinds On

The federal augmentation vote that dominated Brazil's late summer is settled; the harder question it raised is not. The safety review of Somaform Augmetics' neural-interface line remains open and contested this autumn, with regulators, clinicians and augmentation-rights advocates still submitting evidence and no finding issued. At a rehabilitation clinic in São Paulo, neural-interface recipient Beatriz Nogueira, 34, described living inside that uncertainty. "The vote gave me a right; the review will tell me if I was right to use it," she said, flexing a hand her implant helps her control after an injury. Somaform founder Julian Morrow reiterated that the firm "welcomes scrutiny and will not pre-empt it." Roughly five percent of humans are now augmented, a share that makes the review's slowness a feature, not a failure, clinicians argue. "A verdict rushed to reassure people," Nogueira's physician said, "would reassure no one who has read one before."